Podcast: Judgment in the …
Webinar | 7 July 2025 (U.S.) | 8 July 2025 (APAC) | 10:00 a.m. - 11:00 a.m. CST/HKT/SGT | 11:00 a.m. - 12:00 p.m. JST | 10:00 p.m. - 11:00 p.m. EDT
Hogan Lovells APAC Life Sciences and Health Care Webinar Series - Spotlight on the U.S. - Session 8
Webinar No.8: US IPOs for life sciences companies
We are delighted to invite you to the eighth session of our “Spotlight on the U.S.” sessions within our APAC life sciences and health care webinar series on Tuesday, 8 July 2025.
As the U.S. market access landscape grows increasingly complex, this webinar will explore the evolving regulatory environment and provide invaluable insights for life sciences companies exploring a U.S. IPO. We will outline the key strategic decisions and essential workstreams needed to achieve the IPO process smoothly and efficiently.
This session will help you address critical questions such as:
- Is an IPO the right move?
- Why might the U.S. be the best market?
- NASDAQ or NYSE: which is the right exchange for us?
- What are the key financial and operational benchmarks we’ll need to meet for a successful IPO?
- What consequences will U.S. listed-company rules have for our corporate governance?
- We will also cover the SEC registration process; listing structures such as SPACs, direct listings, and traditional IPOs; how leveraging an APAC vehicle can support cross-border success; the life sciences-specific issues that arise in a U.S. IPO; and ongoing compliance obligations.
If you have any questions, please submit them in advance and our speakers will seek to address them during the webinar.
Register here
Back To Listing
